MUMBAI, India, July 11 -- Intellectual Property India has published a patent application (202511059660 A) filed by Isf College Of Pharmacy, Moga, Punjab, on June 21, for 'simultaneous estimation of atorvastatin and bampedoic acid in tablet dosage form by rp-hplc method using qbd and qsrr-based approaches.'
Inventor(s) include Sudarshan Kumar; Vivek Asati; Pavittar Singh; and Ghanshyam Das Gupta.
The application for the patent was published on July 11, under issue no. 28/2025.
According to the abstract released by the Intellectual Property India: "Atorvastatin is an anti-hypercholesterolemic drug used in combination with Bampedoic acid. The combination drug atorvastatin and bampedoic acid, marketed under the brand name Azotar-B80, is a tr...